Observational studyDigestive diseases and sciences2026
The Patient Experience with Point-of-Care Intestinal Ultrasound for Inflammatory Bowel Disease Monitoring: A Multicenter Study.
Observational study in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient Perspectives of Intestinal Ultrasound in IBD: A Quantitative Evaluation of Satisfaction and Diagnostic Preference.Digestive diseases and sciences · 2026Article
- Imaging endpoints in inflammatory bowel disease: current evidence and future directions for ultrasound and MRI.BMC medicine · 2026Review
- Intestinal Ultrasound in Inflammatory Bowel Disease: Monitoring Inflammation and Treatment Response.Journal of inflammation research · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntestinal ultrasound (IUS) is a non-invasive, accurate tool for monitoring inflammatory bowel disease (IBD), with growing adoption in the United States for real-time disease management within treat-to-target algorithms. While international studies highlight strong patient support for IUS, U.S.-based data on patient preferences and engagement are limited.
aimsThis cross-sectional observational study, conducted at two academic IBD centers in the U.S., assessed patient experiences with IUS and preferences for disease monitoring.
methodsAdults with Crohn's disease (CD) and ulcerative colitis (UC) seen for a routine visit were selected to undergo IUS-driven care or non-IUS-driven care, at the discretion of their provider. Participants then completed a 20-item survey, which included Likert scales for comparing disease-monitoring modalities, as well as measures of patient engagement (Patient Activation Measure (PAM-13), Morisky Medication Adherence Scale (MMAS-4)), and disease activity. Electronic health records were reviewed for clinical data.
resultsOf 326 patients (209 (64.1%) with CD; 117 (35.9%) with UC), 219 (67.2%) were IUS exposed (underwent IUS-driven care on the date of survey or previously) and 107 (32.8%) were IUS naïve. 133 (60.7%) IUS-exposed participants expressed a strong preference for IUS when comparing disease-monitoring modalities, with 153 (69.9%) reporting no discomfort. 225/326 (69.0%) expressed the strongest confidence in colonoscopy. 101 (46.1%) IUS-exposed participants expressed stronger confidence in IUS vs. blood work (96; 43.8%), stool studies (78; 35.6%), and other cross-sectional imaging (79; 36.1%).
conclusionIUS is highly acceptable, well tolerated, and preferred by our U.S. POPULATION: These findings support the implementation of IUS as a patient-centric monitoring tool.
Indexed as
Identifiers
40968300What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.